Common-Size Income Statement
Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).
The financial performance from 2012 to 2017 is characterized by consistent gross profit margins and significant volatility in operating expenses and net income, particularly in the latter years of the period.
- Gross Profitability
- Gross profit margins remained relatively stable, fluctuating between a low of 51.50% in 2013 and a high of 54.54% in 2015. The cost of goods sold consistently ranged from 45.46% to 48.50% of net sales, indicating a stable direct cost structure over the six-year period.
- Operating Expense Trends
- Selling, general, and administrative expenses showed a marked increase toward the end of the period, rising from 17.70% in 2012 to a peak of 20.98% in 2016. Research and development expenditures remained consistent, averaging approximately 10.8% of net sales annually. Operating efficiency was further impacted by restructuring charges and transaction-related costs, which became prominent between 2015 and 2017, including costs associated with the Bayer transaction in 2017.
- Operating Income Performance
- Income from operations exhibited a downward trend peaking in 2014 at 25.70% before declining sharply to 17.59% in 2016. This contraction is primarily attributed to the rise in SG&A expenses and the emergence of restructuring charges. A partial recovery was observed in 2017, with the operating margin returning to 21.94%.
- Financial Costs and Tax Provisions
- Interest expenses as a percentage of net sales more than doubled from 1.41% in 2012 to 3.23% in 2016, suggesting an increase in leverage or financing costs. Conversely, the income tax provision showed a gradual decline from 6.67% in 2012 to 4.28% in 2017, which provided some mitigation against falling operating incomes.
- Net Income Margin
- Net income attributable to the company peaked in 2014 at 17.28% of net sales. A significant contraction occurred in 2016, where the margin dropped to 9.89%, the lowest point in the analyzed period. By 2017, the net income margin rebounded to 15.44%, aligning closely with the levels observed at the start of the period in 2012.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?